Company Update Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals Limited receives USFDA Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3%